LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 36.73 | 770.25 | 3727 | 4086 | 0.9121 | 0.9250 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 36.73 | 770.25 | 3631 | 4086 | 0.8886 | 0.9043 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 38.95 | 770.25 | 4220 | 4543 | 0.9287 | 0.9431 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 38.95 | 770.25 | 3950 | 4543 | 0.8693 | 0.8935 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 41.17 | 770.25 | 4604 | 5010 | 0.9189 | 0.9383 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 41.17 | 770.25 | 4237 | 5010 | 0.8456 | 0.8796 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 43.39 | 770.25 | 5005 | 5404 | 0.9261 | 0.9461 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 43.39 | 770.25 | 4560 | 5404 | 0.8438 | 0.8827 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 45.61 | 770.25 | 5222 | 5813 | 0.8983 | 0.9278 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 45.61 | 770.25 | 4966 | 5813 | 0.8543 | 0.8949 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 47.83 | 770.25 | 5614 | 6223 | 0.9021 | 0.9328 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 47.83 | 770.25 | 5325 | 6223 | 0.8556 | 0.8992 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 50.05 | 770.25 | 5963 | 6629 | 0.8995 | 0.9329 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 50.05 | 770.25 | 5785 | 6629 | 0.8726 | 0.9141 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 52.27 | 770.25 | 6400 | 7058 | 0.9067 | 0.9396 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 52.27 | 770.25 | 6074 | 7058 | 0.8605 | 0.9081 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 54.49 | 770.25 | 6833 | 7555 | 0.9044 | 0.9399 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 54.49 | 770.25 | 6452 | 7555 | 0.8540 | 0.9064 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 56.71 | 770.25 | 7237 | 8001 | 0.9044 | 0.9414 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 56.71 | 770.25 | 6859 | 8001 | 0.8572 | 0.9108 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 58.94 | 770.25 | 7727 | 8444 | 0.9151 | 0.9493 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 58.94 | 770.25 | 7298 | 8444 | 0.8642 | 0.9173 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 61.16 | 770.25 | 8148 | 8892 | 0.9163 | 0.9511 | MN20160304_L02 | C19 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 61.16 | 770.25 | 7724 | 8892 | 0.8687 | 0.9218 | MN20160304_L02 | D18 |
MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 63.39 | 770.25 | 8584 | 9326 | 0.9204 | 0.9544 | MN20160304_L02 | C19 |